JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis

GE Fragoulis, IB McInnes, S Siebert - Rheumatology, 2019 - academic.oup.com
Janus kinase (JAK)/signal transducers and activators of transcription (STATs) are a group of
molecules associated with one of the major pathways through which many cytokines exert …

JAK inhibitors for the treatment of autoimmune and inflammatory diseases

Y Jamilloux, T El Jammal, L Vuitton… - Autoimmunity …, 2019 - Elsevier
Cytokines play a central role in the pathophysiology of autoimmune and inflammatory
diseases. Several cytokines signal through the JAK-STAT pathway, which is now recognized …

Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn's disease: a multi-omics Mendelian randomization study

S Xu, X Li, S Zhang, C Qi, Z Zhang, R Ma, L Xiang… - BMC medicine, 2023 - Springer
Background Oxidative stress (OS) is a key pathophysiological mechanism in Crohn's
disease (CD). OS-related genes can be affected by environmental factors, intestinal …

[HTML][HTML] Inflammatory bowel diseases and spondyloarthropathies: from pathogenesis to treatment

GE Fragoulis, C Liava, D Daoussis… - World journal of …, 2019 - ncbi.nlm.nih.gov
Spondyloarthropathies (SpA) include many different forms of inflammatory arthritis and can
affect the spine (axial SpA) and/or peripheral joints (peripheral SpA) with Ankylosing …

MPNs as inflammatory diseases: the evidence, consequences, and perspectives

HC Hasselbalch, ME Bjørn - Mediators of inflammation, 2015 - Wiley Online Library
In recent years the evidence is increasing that chronic inflammation may be an important
driving force for clonal evolution and disease progression in the Philadelphia‐negative …

Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal …

HC Hasselbalch - Blood, The Journal of the American Society …, 2012 - ashpublications.org
The morbidity and mortality of patients with the chronic Philadelphia-negative
myeloproliferative neoplasms (MPNs), essential thrombocythemia, polycythemia vera, and …

[HTML][HTML] Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma

J Lv, L Guo, JJ Liu, HP Zhao, J Zhang… - World journal of …, 2019 - ncbi.nlm.nih.gov
The incidence of esophageal adenocarcinoma (EAC) has increased in recent decades, and
its 5-year survival rate is less than 20%. As a well-established precursor, patients with …

[HTML][HTML] Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease

F Cordes, D Foell, JN Ding, G Varga… - World journal of …, 2020 - ncbi.nlm.nih.gov
In 2018, the pan-Janus kinase (JAK) inhibitor tofacitinib was launched for the treatment of
ulcerative colitis (UC). Although tofacitinib has proven efficacious in patients with active UC …

Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases

A Hosseini, T Gharibi, F Marofi… - Journal of Cellular …, 2020 - Wiley Online Library
Many cytokines are crucial drivers of cancers and autoimmune conditions. These proteins
bind to receptors and signal their responses through Janus kinase (JAK) and signal …

Chronic inflammation and mutagenesis

LR Ferguson - … Research/Fundamental and Molecular Mechanisms of …, 2010 - Elsevier
Inflammation is a necessary part of the immune response. However, when inflammation
persists, the resultant state of chronic inflammation may have a number of secondary …